IperionX Limited (IPX)

IperionX Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Selling, General & Admin	8.16	6.65	6.26	1.56	0.47
Research & Development	8.71	5.6	1.08	-	-
Operating Expenses	22.62	17.66	21.87	8.82	0.55
Operating Income	-22.62	-17.66	-21.87	-8.82	-0.55
Interest Expense	-0.12	-0.09	-0.04	-0	-0
Interest & Investment Income	0.55	0.14	0.4	0.01	0.02
Currency Exchange Gain (Loss)	-0.05	0.35	-	-	-
Other Non Operating Income (Expenses)	0.61	0.06	-0.01	-0	0.03
EBT Excluding Unusual Items	-21.63	-17.19	-21.52	-8.83	-0.52
Gain (Loss) on Sale of Investments	-	-0.25	-	-	-
Gain (Loss) on Sale of Assets	-0.02	-	-	-	-
Asset Writedown	-0.2	-	-	-	-
Other Unusual Items	-	-	-	-5.61	-
Pretax Income	-21.84	-17.44	-21.52	-14.43	-0.52
Net Income	-21.84	-17.44	-21.52	-14.43	-0.52
Net Income to Common	-21.84	-17.44	-21.52	-14.43	-0.52
Shares Outstanding (Basic)	218	168	135	69	31
Shares Outstanding (Diluted)	218	168	135	69	31
Shares Change (YoY)	29.65%	24.83%	95.66%	119.52%	1.41%
EPS (Basic)	-0.10	-0.10	-0.16	-0.21	-0.02
EPS (Diluted)	-0.10	-0.10	-0.16	-0.21	-0.02
Free Cash Flow	-26.68	-18.57	-14.95	-4.51	-0.54
Free Cash Flow Per Share	-0.12	-0.11	-0.11	-0.07	-0.02
EBITDA	-22.49	-17.48	-21.84	-8.82	-0.55
D&A For EBITDA	0.12	0.18	0.03	0	0
EBIT	-22.62	-17.66	-21.87	-8.82	-0.55

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q